These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 36130002)
1. After Metformin - Next Steps for Type 2 Diabetes with Low Cardiovascular Risk. Rydén L; Standl E N Engl J Med; 2022 Sep; 387(12):1136-1138. PubMed ID: 36130002 [No Abstract] [Full Text] [Related]
3. Is metformin more than an oral hypoglycaemic agent? Vague P Diabetes Metab; 2003 Sep; 29(4 Pt 2):6S5-7. PubMed ID: 14502095 [No Abstract] [Full Text] [Related]
4. [Assessment of the management of type 2 diabetes]. Hanaire-Broutin H; Després JP; Dubois-Randé JL; Grimaldi A Presse Med; 2004 Sep; 33(16):1121-3. PubMed ID: 15523273 [No Abstract] [Full Text] [Related]
7. [Anti-diabetic treatment, insulin resistance and cardiovascular disease in patients with type 2 diabetes]. Hemmingsen B; Lund SS; Vaag A Ugeskr Laeger; 2009 May; 171(19):1598-602. PubMed ID: 19419642 [TBL] [Abstract][Full Text] [Related]
8. Incorporating New Medications in Diabetes Care. Comi RJ Ann Intern Med; 2015 Nov; 163(9):719-20. PubMed ID: 26458033 [No Abstract] [Full Text] [Related]
9. Metformin and vascular protection: a cardiologist's view. Libby P Diabetes Metab; 2003 Sep; 29(4 Pt 2):6S117-20. PubMed ID: 14502109 [TBL] [Abstract][Full Text] [Related]
10. Metformin: drug of choice for the prevention of type 2 diabetes and cardiovascular complications in high-risk subjects. Standl E Diabetes Metab; 2003 Sep; 29(4 Pt 2):6S121-2. PubMed ID: 14502110 [TBL] [Abstract][Full Text] [Related]
12. Metformin therapy in diabetes: the role of cardioprotection. El Messaoudi S; Rongen GA; Riksen NP Curr Atheroscler Rep; 2013 Apr; 15(4):314. PubMed ID: 23423523 [TBL] [Abstract][Full Text] [Related]
13. From the World Congress of Cardiology, Barcelona, 2006--Support for wider metformin usage in type 2 diabetes. Cardiovasc J S Afr; 2006; 17(5):267. PubMed ID: 17117236 [No Abstract] [Full Text] [Related]
14. [Thyroid dysfunction in patients with type 2 diabetes mellitus]. Tereshchenko IV; Suslina AA Ter Arkh; 2014; 86(8):119-23. PubMed ID: 25306758 [TBL] [Abstract][Full Text] [Related]
15. The cardiovascular effects of metformin: further reasons to consider an old drug as a cornerstone in the therapy of type 2 diabetes mellitus. Anfossi G; Russo I; Bonomo K; Trovati M Curr Vasc Pharmacol; 2010 May; 8(3):327-37. PubMed ID: 19485923 [TBL] [Abstract][Full Text] [Related]
16. Cardiovascular safety of metformin and sulfonylureas in patients with different cardiac risk profiles. Wurm R; Resl M; Neuhold S; Prager R; Brath H; Francesconi C; Vila G; Strunk G; Clodi M; Luger A; Pacher R; Hülsmann M Heart; 2016 Oct; 102(19):1544-51. PubMed ID: 27226327 [TBL] [Abstract][Full Text] [Related]